Medak Gesellschaft fuer klinische Spezialpraparate mbH (manufacturer responsible for secondary packaging; manufacturer responsible for secondary packaging, labeling, control/testing of batch and batch release)

Ukraine

All drugs from this manufacturer

  • METHOJEKT

    The drug is used to treat the active form of rheumatoid arthritis in adults, severe forms of psoriasis and psoriatic arthritis, as well as for the therapy of Crohn's disease.

    Dosage form: solution for injection

    Active substance Dosage
    methotrexate 50 mg/ml

    ATC: L04AX03